Envestnet, Inc.
ENV
had an impressive run over the past three months. The stock gained 32.5% compared with the 7.2% rally of the
industry
it belongs to and the 0.7% rise of the Zacks S&P 500 composite.
Reasons for the Upside
Envestnet’s business model ensures solid asset-based and subscription-based recurring revenue-generation capacity. ENV provides asset-based and subscription-based services on a business-to-business-to-consumer basis to financial services clients. These clients offer solutions based on ENV’s platform to their end users.
Several trends are creating significant market opportunities for Envestnet’s technology-enabled solutions and services. Investment advice is becoming an important part of financial planning and customers are increasingly seeking personalized wealth management services. Technology adoption is also increasing significantly with the increasing need to interact with clients who prefer guided advice in a cost-effective manner.
Envestnet continues to focus on technology development with a view to improving operational efficiency, increasing market competitiveness, addressing regulatory demands and catering to client-driven requests for new capabilities. It believes that its technology design allows for significant scalability.
Envestnet’s earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering a positive average earnings surprise of 5%.
Zacks Rank and Stocks to Consider
ENV currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks
Business Services
sector are
Booz Allen Hamilton Holding Corporation
BAH
and
Cross Country Healthcare, Inc.
CCRN
.
Booz Allen carries a Zacks Rank #2 (Buy) at present. BAH has a long-term earnings growth expectation of 8.9%. You can see
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Booz Allen delivered a trailing four-quarter earnings surprise of 8.8% on average.
Cross Country Healthcare is currently a Zacks #2 Ranked stock. CCRN has a long-term earnings growth expectation of 6%.
CCRN delivered a trailing four-quarter earnings surprise of 10.1% on average.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
